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  Nine preoperative bladder cancer patients were submitted to lccal injection therapy．
  Using a 26 gauge needle， BCG 1 × 107 cellsfO．5 ml was injected into the stalk of the tumor under
an endoscopic procedure． Two weeks later the second injection was performed by the same methcd．
Cys亡oscopic， hematological， immunQlogical and histological examination were made during the
observation．
  One out ofnine patients showed disappearance ofthe tumor after about three months observation．
  Histological change after BCG injection was as same as that after adriamycin injection．
  There was no adverse reaction such as fever and granulomatous reaction．
  Although these result are still preliminary， it seems to be usefu1 for an evaluation of immunological
response and a new therapeutic approach to tumor．














































































         Table 全症例の一一｝S表
しocal i njection of BCG against blackier carcinoma
        コ  の
Cas∈age sex G． S，
BcG LyrnFtK）cytes／mm3 S．1． 3） PpD
































































































1 j G．／Grade of tumor by Broders classification
2 ） S ’Stage ef tumor by Jewett－MarshalL classification
3 ） S 1，／PHA induced bbastogenesds of lympliocyte． 5timulaUoc lndex
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  びらん面、間質の硬化
Fig・3・BCG局注時の組織変化．
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Fig．4．症例（Case 12）の経過図
Fig．5．症例（Case l 2）におけるBGG局所注入前後の膀胱鏡写真，腫瘍の消失を認める
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